HLA and cancer: from research to clinical impact

被引：58

作者：

Ruiz-Cabello, F ^{[1
]}

Garrido, F ^{[1
]}

机构：

[1] Hosp Univ Virgen Nieves, Dept Anal Clin, Granada 18014, Spain

来源：

IMMUNOLOGY TODAY | 1998年 / 19卷 / 12期

关键词：

D O I：

10.1016/S0167-5699(98)01349-8

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

The identification of different mechanisms by which tumours escape from the immune system have helped to judge the clinical relevance of several phenotypic changes that occur during tumour development. As discussed at a recent meeting*, changes in HLA class I expression play a leading role in the tumour-host scenario.

引用

页码：539 / 542

页数：4

共 16 条

[1]

Bartholomew JS, 1997, CANCER RES, V57, P937

[2] Specific HLA class I down-regulation is an early event in cervical dysplasia associated with clinical progression [J].

Bontkes, HJ ;

Walboomers, JMM ;

Meijer, CJLM ;

Helmerhorst, TJM ;

Stern, PL .

LANCET, 1998, 351 (9097) :187-188

[3] TUMOR-ANTIGENS RECOGNIZED BY T-LYMPHOCYTES [J].

BOON, T ;

CEROTTINI, JC ;

VANDENEYNDE, B ;

VANDERBRUGGEN, P ;

VANPEL, A .

ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 :337-365

[4] Mechanisms of loss of HLA class I expression on colorectal tumor cells [J].

Browning, M ;

Petronzelli, F ;

Bicknell, D ;

Krausa, P ;

Rowan, A ;

Tonks, S ;

Murray, N ;

Bodmer, J ;

Bodmer, W .

TISSUE ANTIGENS, 1996, 47 (05) :364-371

[5] THE BIOLOGICAL CONSEQUENCES OF ALTERED MHC EXPRESSION ON TUMORS [J].

FESTENSTEIN, H .

BRITISH MEDICAL BULLETIN, 1987, 43 (01) :217-227

[6] Implications for immunosurveillance of altered HLA class I phenotypes in human tumours [J].

Garrido, F ;

RuizCabello, F ;

Cabrera, T ;

PerezVillar, JJ ;

LopezBotet, M ;

DugganKeen, M ;

Stern, PL .

IMMUNOLOGY TODAY, 1997, 18 (02) :89-95

[7] HLA class I antigens in human tumors [J].

Garrido, F ;

Cabrera, T ;

LopezNevot, MA ;

RuizCabello, F .

ADVANCES IN CANCER RESEARCH, VOL 67, 1995, 67 :155-195

[8] FURTHER EVIDENCE FOR DEREPRESSION OF H-2 AND IA-LIKE SPECIFICITIES OF FOREIGN HAPLOTYPES IN MOUSE TUMOR-CELL LINES [J].

GARRIDO, F ;

FESTENSTEIN, H ;

SCHIRRMACHER, V .

NATURE, 1976, 261 (5562) :705-707

[9] Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor [J].

Ikeda, H ;

Lethe, B ;

Lehmann, F ;

VanBaren, N ;

Baurain, JF ;

DeSmet, C ;

Chambost, H ;

Vitale, M ;

Moretta, A ;

Boon, T ;

Coulie, PG .

IMMUNITY, 1997, 6 (02) :199-208

[10]

KAKLAMANIS L, 1992, CANCER SURV, V13, P155

← 1 2 →